News

Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) today announced that Lilly has submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for the approval of oral once-daily baricitinib for the...

Eli Lilly and Company (NYSE: LLY) today announced an arrangement to partner with Roche Diagnostics on its ongoing development of a commercially scalable cerebrospinal fluid assay for amyloid-beta 1-42. Together with tau tangles, the presence of...

The Industry ConnectThe Asia-Pacific biotechnology industry has been witnessing a growth phase on the back of several factors, such as cost effective manufacturing capabilities, improved clinical capabilities, growing health needs of large population base, exports and increasing government support...

Lecture series aims to inspire young scientists in Shanghai and Chengdu This week, Nobel Laureate Tim Hunt will give a series of lectures to students and faculty at Shanghai’s Fudan University School of Pharmacy and Chengdu’s Sichuan University West...

AstraZeneca and Cancer Research UK today announced that they have signed a memorandum of understanding through which Cancer Research UK drug discovery investigators would be given access to state-of-the-art drug discovery facilities at the new AstraZeneca MRC UK Centre...

TV spot showcases the science behind the ultimate breathability and comfort of DAILIES TOTAL1® contact lenses Fort Worth, Texas- Alcon, the global leader in eye care and division of Novartis, has launched a national television campaign...

The largest completed study to date on treatments to reduce recurrence of blood clots in cancer patients, sponsored by LEO Pharma, has now been published in JAMA (The Journal of American Medical Association) JAMA. 2015;314(7):677-686. The...